India will have COVID-19 vaccine within days: Dr Randeep Guleria ANI | Updated: Dec 31, 2020 01:30 IST
New Delhi [India], December 30 (ANI): Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a big step forward , AIIMS Delhi Director Dr Randeep Guleria on Wednesday said that India will have the COVID-19 vaccine within days. This is very good news that AstraZeneca got approval for its vaccine by UK regulatory authorities. They have robust data and in India and the same vaccine is being developed by the Serum Institute of India. This is a big step forward not only for India but many parts of the world, Guleria told ANI in an interview.
India will have COVID-19 vaccine within days: Dr Guleria indiagazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiagazette.com Daily Mail and Mail on Sunday newspapers.
NEW DELHI: India began a two-day dry run for coronavirus vaccination in four states across the country on Monday in preparation for a full roll-out in the near future.
The trial covers the northeastern state of Assam, the northern state of Punjab, the southern state of Andhra Pradesh and the western state of Gujarat. Two districts from each of these states will be involved.
“Today we will be having the dry run for the COVID-19 vaccine in both urban and rural areas,” civil surgeon in the Punjab-based Ludhiana district, Dr. Rajesh Kumar Bagga, told Arab News.
Seven booths have been set up in the district and each booth will vaccinate 25 people.
Explained: What is India’s first indigenously created vaccine against pneumococcal disease?
Pneumococcal disease is a significant contributor under-five mortality rate worldwide. Updated: January 1, 2021 12:44:47 pm
The vaccine, Pneumosil, will be available shortly. (Serum Institute of India)
Pune-based Serum Institute of India (SII)
unveiled India’s first indigenously developed pneumococcal vaccine on Monday. The world’s largest vaccine manufacturer by doses, SII is also the maker of Covishield, the Indian version of the AstraZeneca-Oxford coronavirus vaccine.
SII’s pneumococcal vaccine, Pneumosil, was developed through a collaboration spanning over a decade with the health organisation PATH and the Bill and Melinda Gates Foundation. The vaccine was launched by Union Health Minister Dr Harsh Vardhan. “This is a significant milestone for the country’s public healthcare which will ensure that children are protected better against
India is considering three coronavirus vaccines for emergency use authorisation (File)
New Delhi:
Existing coronavirus vaccines will work against mutated strains of the virus that have emerged from the United Kingdom and South Africa in recent months, the Health Ministry said at its Tuesday briefing.
The ministry was responding to fears the first lot of vaccines will be ineffective against aggressive variants of a virus that has already infected over a crore and killed 1.5 lakh people in India alone. There is no evidence current vaccines will fail to protect against COVID-19 variants from the UK or South Africa, Professor K VijayRaghavan, the government s Principal Scientific Adviser, said.